首页> 外文期刊>Guthrie Journal >The Peripheral Venous Access Port: A Safe and Cost-effective Alternative to Chest Ports
【24h】

The Peripheral Venous Access Port: A Safe and Cost-effective Alternative to Chest Ports

机译:外围静脉通路端口:安全,经济的胸口端口替代方案

获取原文
获取原文并翻译 | 示例
       

摘要

Peripherally implanted venous access ports have been available for several years, but their use varies greatly among surgeons and oncologists. We have evaluated the ease of insertion and complication rate associated with the peripheral port and reviewed the literature on this new device. From January 1993 to November 1994, a peripheral venous access device (P.A.S. Port™) was placed in 44 patients who required long-term intravenous therapy. Data on post-operative and delayed complications were collected on all patients using inpa-tient and outpatient records. The follow-up period ranged from 11 to 685 days with a total usage of 11,695 days. The P.A.S. Port™ was easily inserted in the outpatient setting under local anesthesia. Perioperative complications included phlebitis in two patients and infection in one. Delayed complications included axillary vein thrombosis (one patient), port site infection (one patient), and irreversible catheter occlusion (one patient). The complication rate was 0.51 per 1000 catheter days. Review of the literature shows that peripherally inserted venous access devices compare favorably to centrally inserted ports in ease of use and complication rate. Complications of pneumothorax and vascular injury associated with central insertion are eliminated. Insertion of the device in the outpatient setting under local anesthesia should result in a significant reduction of insertion-related morbidity and in substantial reduction in cost over chest ports.
机译:周围植入的静脉进入端口已经使用了数年,但是在外科医生和肿瘤科医生之间,它们的使用差异很大。我们评估了与外围端口相关的插入和并发症的难易程度,并回顾了有关这种新设备的文献。从1993年1月至1994年11月,为需要长期静脉内治疗的44例患者放置了外周静脉通路设备(P.A.S. Port™)。使用住院和门诊记录收集所有患者的术后并发症和延迟并发症的数据。随访时间为11至685天,总使用时间为11695天。 P.A.S. Port™可以在局部麻醉下轻松插入门诊。围手术期并发症包括2例静脉炎和1例感染。延迟并发症包括腋静脉血栓形成(一名患者),端口部位感染(一名患者)和不可逆导管阻塞(一名患者)。并发症发生率为0.5 / 1000导管天。文献综述表明,在使用方便和并发症发生率方面,外围插入的静脉通路装置比中心插入的端口优越。消除了与中心插入相关的气胸并发症和血管损伤。在局部麻醉下在门诊环境中插入设备应可显着降低与插入相关的发病率,并大大降低经胸口的费用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号